Resultados de la búsqueda

Toribio-Fernández R, Tristão-Pereira C, Carlos Silla-Castro J, Callejas S, Oliva B, Fernandez-Nueda I, Garcia-Lunar I, Perez-Herreras C, María Ordovás J, Martin P, Blanco-Kelly F, Ayuso C, Lara-Pezzi E, Fernandez-Ortiz A, Garcia-Alvarez A, Dopazo A, Sanchez-Cabo F, Ibanez B, Cortes-Canteli M, Fuster V. Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study Circ Res (2024) 134:411-424.
Link to the full text in Repisalud

Zeng Q, Oliva VM, Moro MÁ, Scheiermann C. Circadian Effects on Vascular Immunopathologies. Circ Res (2024) 134:791-809.
Link to the full text in Repisalud

Cruz FM, Macías Á, Moreno-Manuel AI, Gutiérrez LK, Vera-Pedrosa ML, Martínez-Carrascoso I, Sánchez Pérez P, Ruiz Robles JM, Bermúdez-Jiménez FJ, Díaz-Agustín A, Martínez de Benito F, Arias-Santiago S, Braza-Boils A, Martín-Martínez M, Gutierrez-Rodríguez M, Bernal JA, Zorio E, Jiménez-Jaimez J, Jalife J. Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome Circ Res (2024) 134:e52-e71.
Link to the full text in Repisalud

Douvdevany G, Erlich I, Haimovich-Caspi L, Mashiah T, Prondzynski M, Pricolo MR, Alegre-Cebollada J, Linke WA, Carrier L, Kehat I. Imaging of Existing and Newly Translated Proteins Elucidates Mechanisms of Sarcomere Turnover. Circ Res (2024) 135:474-487

Elliott P, Gundapaneni B, Garcia-Pavia P. Reply to 'Effects of tafamidis on heart failure hospitalization: The tale of the dog that did not bark'. Eur J Heart Fail (2024) 26:526-527
Link to the full text in Repisalud

Ferreira JP, Rossello X, Zannad F. Mineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial infarction patients Eur J Heart Fail (2024) 26:140-141

González-Del-Hoyo M, Rossello X. Worsening heart failure comes into focus, chronic heart failure takes a backseat. Eur J Heart Fail (2024) 26:230-232.

Coughlan JJ, Rossello X. Anaemia in patients with cardiogenic shock complicating acute myocardial infarction: Surrogate marker of poor outcome or therapeutic target? Eur J Heart Fail (2024) 26:458-459.

Garcia-Pavia P, Grogan M, Kale P, Berk JL, Maurer MS, Conceição I, Di Carli M, Solomon SD, Chen C, Yureneva E, Vest J, Gillmore JD. Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy. Eur J Heart Fail (2024) 26:397-410
Link to the full text in Repisalud

Pascual-Figal DA, Hernández-Vicente A, Pastor-Pérez F, Martínez-Sellés M, Solé-González E, Alvarez-García J, García-Pavía P, Varela-Román A, Sánchez PL, Delgado JF, Noguera-Velasco JA, Bayes-Genis A; NICE study investigators. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction - a randomized trial: The NICE study. Eur J Heart Fail (2024) 26:776-784.
Link to the full text in Repisalud